At the time of the creation of this website, there were no clinical study outcome-based guidelines for the management of these dermatological toxicities. As such, treatment algorithms described on this website are largely compiled from expert statements, literature review (of review articles, reports of small cohort studies and limited data from small prospective, randomised clinical trials) and expert guidance from a dermatologist, Professor Siegfried Segaert (University Hospital Leuven, Leuven, Belgium), and an oncology nurse Liesbeth Lemmens (University Hospital Leuven, Leuven, Belgium).

[Update: In 2011, the MASCC published a Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.]

This section of the website provides links for downloading published literature, international and national guidelines, HCP and patient guides, and links to related websites. Links to literature and other websites of interest are provided for your information only and do not necessarily reflect the opinion of ESMO. Access to these articles and websites will be based on your current access and/or subscriptions, ESMO does not take responsibility for supplying access to this information.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings